Insys Wins Coming and Going with Fentanyl, Naloxone Formulations

The federal government gave the green light to fast track development of an opioid overdose antidote to a pharmaceutical company that earlier this year paid Oregon more than $1 million for marketing its fentanyl spray for off-label uses and faces similar investigations in other jurisdictions. The irony wasn't lost on Mark Pew, senior vice president for Prium. "They create the demand; then they create the solution," he said. Insys said in its Nov. 5 quarterly filing to the U.S. Securities and Exchange Commission it has made $238.4 million from the sale of Subsys throu...